StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Regen BioPharma's pe ratio was 1.8× on Jan 31, 2024, against 500.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20241.8×+0.1
2023Dec 29, 20231.6×−2.4
2022Dec 30, 20224.0×−496.0
2021Mar 31, 2021500.0×+125.0
2020Dec 31, 2020375.0×–

More Regen BioPharma figures

See a number that looks wrong?